2002
DOI: 10.1038/sj/eye/6700034
|View full text |Cite
|
Sign up to set email alerts
|

Severe progression of glaucomatous optic neuropathy in patients with Alzheimer’s disease

Abstract: 209stimulating hormone level of 21.7 mu/l (normal 0.5-5.0), but serum thyroxine was normal. Other routine bloods including full blood count, urea and electrolytes, serum glucose and liver function tests were also normal. Thyroid autoantibodies and TSH receptor assays were not performed. This subclinical hypothyroidism 1 supported our diagnosis of dysthyroid ocular myopathy. Treatment with oral thyroxine was commenced with a subsequent reduction in this patient's serum cholesterol. He remains visually asymptoma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(11 citation statements)
references
References 5 publications
0
11
0
Order By: Relevance
“…A greater than 10%/year decay in visual field and optic disc cupping were demonstrated in glaucoma patients who were later diagnosed with AD, whereas an average 3%/year decay in visual field was observed in glaucoma patients who did not develop AD, indicating that AD accelerates the progression of glaucoma symptoms [126]. However, increased rates of visual field defects and/or optic disc cupping have also been reported in Parkinson's disease [125] and since these changes are observed in the common eye disease glaucoma, they are unlikely to provide a test that has specificity for AD.…”
Section: (Figure 7)mentioning
confidence: 98%
See 1 more Smart Citation
“…A greater than 10%/year decay in visual field and optic disc cupping were demonstrated in glaucoma patients who were later diagnosed with AD, whereas an average 3%/year decay in visual field was observed in glaucoma patients who did not develop AD, indicating that AD accelerates the progression of glaucoma symptoms [126]. However, increased rates of visual field defects and/or optic disc cupping have also been reported in Parkinson's disease [125] and since these changes are observed in the common eye disease glaucoma, they are unlikely to provide a test that has specificity for AD.…”
Section: (Figure 7)mentioning
confidence: 98%
“…This change in protein levels is similar to that observed in the CSF in AD. Given the retinal degeneration observed in AD [119][120][121][122][123] and the recently reported common features between AD and glaucoma [61,107,[121][122][123][124][125][126][127][128][129][130], the vitreous humor is an interesting focus for future research into ocular protein changes in AD.…”
Section: (Figure 3)mentioning
confidence: 99%
“…However, given no AD patients had ocular hypertension (in comparison with 7.5% of controls) and had no family history of glaucoma, it may be visual field abnormalities were not due to glaucoma and reflect difficulties in performing psychophysical visual field tests in AD patients. A subsequent study by the same authors 54 showed an accelerated progression of visual field defects in patients with open-angle glaucoma and AD when compared with patients with open-angle glaucoma but without AD. However, given possible selection bias, a small sample size, non-blinded observers, and use of fundus photographs rather than more objective RNFL measures, these results need to be considered with caution.…”
Section: Glaucoma and Admentioning
confidence: 99%
“…In favor of this hypothesis, some studies have reported that amyloid-beta, a substance found in cerebral tissues of AD patients, is also implicated in RGC death [10]. Conversely, other studies have shown a relatively higher occurrence of POAG in AD patients [11][12][13][14][15][16][17][18]. …”
mentioning
confidence: 85%